Technical Analysis for NPHC - Nutra Pharma Corp

Grade Last Price % Change Price Change
grade B 0.0004 33.33% 0.0001
NPHC closed up 33.33 percent on Friday, August 16, 2019, on 1.35 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NPHC trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%

Older signals for NPHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Nutra Pharma Corp. is a biopharmaceutical company. The Company is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's subsidiary and drug discovery arm, ReceptoPharm, Inc. (ReceptoPharm), carries its homeopathic and drug discovery research and clinical development and has developed homeopathic drugs for the treatment of pain: Cobroxin, an over-the-counter pain reliever designed to treat moderate to severe (Stage II) chronic pain; Nyloxin and Nyloxin Extra Strength, stronger versions of Cobroxin, and Pet Pain-Away, an over-the-counter pain reliever designed to treat pain in cats and dogs. It has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases, and RPI-MN, to treat viral diseases.
Medicine Health Cancer Pharmaceutical Industry Biopharmaceutical Pain Medication Pharmaceutical Products Drug Discovery Autoimmune Diseases Chronic Pain Neurological Disorders Autoimmunity Drug Pseudoscience Homeopathy Viral Diseases Autoimmune And Infectious Diseases
Is NPHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.0009
52 Week Low 0.0001
Average Volume 5,221,633
200-Day Moving Average 0.0003
50-Day Moving Average 0.0003
20-Day Moving Average 0.0003
10-Day Moving Average 0.0003
Average True Range 0.0007
ADX 2.2
+DI 77.7778
-DI 77.7778
Chandelier Exit (Long, 3 ATRs ) -0.0016
Chandelier Exit (Short, 3 ATRs ) 0.0023
Upper Bollinger Band 0.0004
Lower Bollinger Band 0.0002
Percent B (%b) 1.0
BandWidth 66.666667
MACD Line -0.0003
MACD Signal Line -0.0001
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0006
Resistance 3 (R3) 0.0005 0.0005 0.0005
Resistance 2 (R2) 0.0005 0.0004 0.0005 0.0005
Resistance 1 (R1) 0.0004 0.0004 0.0005 0.0005 0.0005
Pivot Point 0.0004 0.0004 0.0004 0.0004 0.0004
Support 1 (S1) 0.0003 0.0003 0.0004 0.0004 0.0003
Support 2 (S2) 0.0003 0.0003 0.0003 0.0003
Support 3 (S3) 0.0002 0.0003 0.0003
Support 4 (S4) 0.0003